Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nasal budesonide spray versus oral loratadine + montelukast for persistent allergic rhinitis
RBR-10b4gnqsPhase 4Completed
- Sponsor
- São Leopoldo Mandic
- Start
- Jul 2025
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in allergic rhinitis (AR) comparing Budesonide nasal spray with Loratadine + montelukast tablets (2 arms). Started Jul 2025; status: completed.
02
Drugs
budesonideloratadinemontelukast
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on RBR-10b4gnqs.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-10b4gnqs.